Nexgen Mold & Tool, Inc. v. Precise Tooling Solutions, Inc. (mem. dec.) ( 2020 )


Menu:
  •       MEMORANDUM DECISION
    Pursuant to Ind. Appellate Rule 65(D),                                    FILED
    this Memorandum Decision shall not be
    Jan 31 2020, 6:27 am
    regarded as precedent or cited before any
    court except for the purpose of establishing                              CLERK
    Indiana Supreme Court
    the defense of res judicata, collateral                                  Court of Appeals
    and Tax Court
    estoppel, or the law of the case.
    ATTORNEY FOR APPELLANT                                   ATTORNEY FOR APPELLEE
    Bryan L. Ciyou                                           Dane A. Mize
    Ciyou & Dixon, P.C.                                      Skiles DeTrude
    Indianapolis, Indiana                                    Indianapolis, Indiana
    IN THE
    COURT OF APPEALS OF INDIANA
    Nexgen Mold & Tool, Inc.,                                January 31, 2020
    Appellant-Defendant,                                     Court of Appeals Case No.
    19A-CT-1369
    v.                                               Appeal from the Bartholomew
    Superior Court
    Precise Tooling Solutions, Inc.,                         The Honorable Kathleen Tighe
    Appellee-Plaintiff.                                      Coriden, Judge
    Trial Court Cause No.
    03D02-1804-CT-2183
    Friedlander, Senior Judge.
    [1]   Nexgen Mold & Tool, Inc., appeals the trial court’s entry of judgment in favor
    of Precise Tooling Solutions, Inc. On cross-appeal, Precise requests an award
    of appellate attorney’s fees. We affirm and remand.
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020              Page 1 of 11
    [2]   Precise is an Indiana-based company that manufactures tools, also known as
    molds, for the plastic injection molding industry. Nexgen is an Indiana-based
    company that also manufactures tools.
    [3]   Nexgen was contracted to redesign and build a tool that would be used to
    manufacture a portion of an automobile’s dashboard. Nexgen was too busy to
    do the work in-house, so it contacted Precise and provided plans for the tool.
    On July 24, 2017, Precise sent Quote Number 5444 to Nexgen. In the quote,
    Precise stated it would “design and make new core and cavity inserts and cavity
    subs . . . fit to existing tool,” for $65,450. Tr. Vol. 3, p. 5 (Ex. 1).
    [4]   On July 26, 2017, Nexgen sent Purchase Order 13251 to Precise. Nexgen
    agreed to Precise’s quoted price, to be paid “30% Down, 60% @1st Smple [sic],
    10% @Apprvl [sic].” Tr. Vol. 3, p. 6 (Ex. 2). The “first sample” is the initial
    version of the tool. Tr. Vol. 2, p. 10. Don Dumoulin, Precise’s owner,
    explained that in the plastic injection molding industry, the first sample is “very
    rarely” the final, correct version of the tool. 
    Id. To the
    contrary, it is common
    for the customer to identify defects in the tool through testing, and the
    manufacturer works with the customer to produce “maturation[s],” or
    “trial[s],” of the part until it is finally approved for use in mass manufacturing.
    
    Id. at 10,
    15.
    [5]   The purchase order set forth a “Promise Date” of September 13, 2017. Tr. Vol.
    3, p. 6. Nexgen paid the down payment to Precise per the terms of the order,
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020   Page 2 of 11
    and Precise sent the first sample of the tool to Nexgen on September 13, 2017.
    Tr. Vol. 2, p. 14.
    [6]   On September 14, 2017, Scott Nickerson, an employee of Precise, sent Kevin
    Gancher, an employee of Nexgen, an email asking if the tool was satisfactory.
    Gancher indicated the tool had defects and possibly some damage. Nickerson
    responded, “Let us know what we can do.” Tr. Vol. 3, p. 9 (Ex. 5). Next,
    Gancher emailed Nickerson images of some of the defects. Precise picked up
    the tool and made corrections.
    [7]   On September 26, 2017, Precise sent Nexgen a second trial of the tool. Three
    days later, Gancher sent Nickerson an email detailing defects in the revised
    copy. Precise picked up the tool and performed additional work.
    [8]   Meanwhile, on September 27, Precise sent Nexgen an invoice for 60% of the
    agreed-upon price for delivery of the first sample. On October 3, 2017, a
    Nexgen employee emailed Tiffanny Laker, Precise’s office manager, to request
    a current statement of what Nexgen owed Precise. Laker sent the employee a
    statement indicating that Nexgen owed $39,270.00.
    [9]   On October 13, 2017, Precise sent to Nexgen a third trial of the tool. In an
    October 19, 2017 email, Gancher told Nickerson he had consulted with the
    customer and identified additional defects. Precise retrieved the tool and
    attempted to address the issues identified by Nexgen.
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020   Page 3 of 11
    [10]   On October 30, Precise sent Nexgen a fourth trial of the tool. On November 6,
    2017, Gancher emailed Nickerson to identify a different defect and to ask
    Precise “to pick up the tool to repair this area.” Tr. Vol. 3, p. 31 (Ex. 12).
    Precise picked up the tool and performed additional work.
    [11]   On November 21, 2017, Precise sent Nexgen a fifth trial of the tool. Also on
    that day, Laker emailed Gancher a final invoice for the tool and asked when
    Precise could expect payment for the “60% invoice.” Tr. Vol. 3, p. 40 (Ex. 15).
    Gancher acknowledged receipt of the fifth trial and indicated it would be
    submitted to final testing to see if it was satisfactory. He asked Laker to
    resubmit the final invoice on December 1, 2017, when the testing should be
    complete. Gancher did not discuss the prior invoice. Later that day, Laker
    emailed Gancher to indicate the final invoice would be resubmitted on
    December 1. She again asked him for information about payment for Precise’s
    prior invoice, and he did not respond. Neither Gancher nor any other Nexgen
    employee contacted Precise to discuss the test results for the fifth trial or to
    identify any uncorrected or newly-discovered defects.
    [12]   In the meantime, on September 28, 2017, Precise and Nexgen had entered into
    a separate agreement under Quote Number 5663 and Purchase Order 13311,
    pursuant to which Precise agreed to produce another tool for Nexgen at a cost
    of $4,233.00.
    [13]   On January 12, 2018, Don Dumoulin, Precise’s owner, emailed John Lukes,
    Nexgen’s owner, to request payment of Precise’s pending invoices. Lukes
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020   Page 4 of 11
    indicated he was out of the office and would respond soon. On February 1,
    2018, Dumoulin emailed Lukes again, noting payment was “[n]ow 90+ days
    overdue.” Tr. Vol. 3, p. 46 (Ex. 17). Lukes and Dumoulin scheduled a
    meeting, but Lukes canceled it two hours before the meeting was scheduled to
    begin.
    [14]   On February 5, 2018, Nexgen notified Precise to stop work on the project under
    Purchase Order 13311. Precise had already begun to manufacture the tool and
    asked Nexgen to pay $3,950.00 for the work that had been done. Nexgen did
    not provide payment.
    [15]   Dumoulin continued to contact Lukes to request payment, but Nexgen did not
    follow through. When Dumoulin threatened a lawsuit over the unpaid
    invoices, Lukes responded that Nexgen was experiencing “a cash crunch” and
    was unable to pay Precise because Nexgen had not yet been paid for the job
    either. Tr. Vol. 3, p. 61 (Ex. 22). In a February 28, 2018 email to Lukes,
    Dumoulin apologized for the delay and promised payment in the next two
    weeks. Other than the thirty percent down payment, Nexgen did not pay
    Precise any funds owed under Purchase Order 13251, and Nexgen never paid
    Precise any money for Precise’s work under Purchase Order 13311.
    [16]   On April 19, 2018, Precise filed a complaint against Nexgen, alleging two
    counts of breach of contract (one for each purchase order) and one count of
    unjust enrichment. Nexgen filed an answer denying Precise’s allegations. The
    parties attended mediation but failed to reach a settlement.
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020   Page 5 of 11
    [17]   On April 26, 2019, the trial judge presided over a bench trial. Next, the parties
    filed proposed findings of fact and conclusions thereon. May 16, 2019, the
    court issued findings of fact and conclusions thereon, and issued a judgment in
    favor of Precise on both of its claims of breach of contract. The court rejected
    as moot Precise’s claim of unjust enrichment. The court ordered Nexgen to pay
    Precise $63,668.18, which included prejudgment interest, plus attorney’s fees.
    The court ordered Precise to submit an affidavit of attorney’s fees.
    [18]   Precise filed an affidavit of attorney’s fees, and Nexgen filed a response. On
    June 12, 2019, the court awarded attorney’s fees to Precise in the amount of
    $11,113.76. This appeal followed.
    [19]   The trial court issued findings of fact and conclusions thereon at Nexgen’s
    1
    request. “On appeal of claims tried by the court . . . , the court on appeal shall
    not set aside the findings or judgment unless clearly erroneous, and due regard
    shall be given to the opportunity of the trial court to judge the credibility of the
    witnesses.” Ind. Trial Rule 52(A).
    [20]   A panel of this court has explained that, pursuant to Trial Rule 52(A), we
    apply a two-tiered review of a trial court’s findings and conclusions: “first, we
    consider whether the evidence supports the findings; second, we determine
    whether those findings support the trial court’s judgment.” Kishpaugh v.
    1
    We thank the trial court for its detailed findings and conclusions, which greatly assisted the Court in
    addressing the issues on appeal.
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020                   Page 6 of 11
    Odegard, 
    17 N.E.3d 363
    , 370 (Ind. Ct. App. 2014). The trial court’s findings
    and judgment will be set aside only if they are clearly erroneous. Shelby’s
    Landing-II, Inc. v. PNC Multifamily Capital Inst. Fund XXVI Ltd. P’ship, 
    65 N.E.3d 1103
    (Ind. Ct. App. 2016).
    [21]   Findings of fact are clearly erroneous when the record lacks any evidence or
    reasonable inferences from the evidence to support them. Mullis v. Brennan, 
    716 N.E.2d 58
    (Ind. Ct. App. 1999). A judgment is clearly erroneous when a
    review of the record leaves us with a firm conviction that a mistake has been
    made. In re Estate of Johnson, 
    855 N.E.2d 686
    (Ind. Ct. App. 2006), trans. denied.
    We neither reweigh the evidence nor assess the credibility of witnesses but
    2
    consider only the evidence most favorable to the judgment. 
    Id. [22] The
    essential elements of a breach of contract claim are the existence of a
    contract, the defendant’s violation of the terms of the contract, and damages.
    Fowler v. Campbell, 
    612 N.E.2d 596
    (Ind. Ct. App. 1993). The parties agree that
    they had a binding contract based on Quote Number 5444 and Purchase Order
    3
    13251. Further, Nexgen does not dispute that it failed to pay Precise the full
    amount owed under the contract. Nexgen instead argues that Precise breached
    2
    The Statement of Facts in Nexgen’s Appellant’s Brief fails to set forth the evidence most favorable to the
    judgment, which hindered our review of the case.
    3
    Nexgen does not raise any issue on appeal regarding breach of the parties’ separate contract under Quote
    Number 5663 and Purchase Order 13311, so we need not address that portion of the trial court’s judgment.
    We also need not address the question of unjust enrichment.
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020                   Page 7 of 11
    the contract first by failing to timely deliver a tool that met the contractual
    requirements.
    [23]   The record does not support Nexgen’s argument as to timeliness. Purchase
    Order 13251 included a “Promise Date” of September 13, 2017. Tr. Vol. 3, p. 6
    (Ex. 2). On September 13, 2017, Precise sent the first sample of the tool to
    Nexgen. As noted, in the plastic injection molding industry it is “very
    common” for a manufacturer to deliver the first sample of a tool and then
    produce additional trials of the tool as defects are revealed during testing. Tr.
    Vol. 2, p. 15. This business practice explains why the Purchase Order called for
    Nexgen to provide an installment payment upon delivery of the first sample and
    then again upon final approval of the tool. In addition, the record contains a
    lengthy exchange of emails by Gancher and Nickerson as they discussed
    different trials of the tool. Neither Gancher nor any other Nexgen employee
    complained that the tool was late or that Precise had missed the contractual
    deadline, even after Precise made repeated demands for payment.
    [24]   Further, neither Gancher nor any other Nexgen employee ever told Precise that
    the dashboard manufacturer had penalized Nexgen for untimely delivery of the
    tool or otherwise complained. To the contrary, Lukes, in his emails to
    Dumoulin, complained about payment delays by the customer rather than any
    pressure from the customer for an alleged untimely delivery. This evidence
    supports the trial court’s determination that Precise met the deadline by timely
    delivering the first sample.
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020   Page 8 of 11
    [25]   In addition, the evidence supports the trial court’s conclusion that the tool
    complied with contractual requirements. After Precise delivered the first
    sample on September 13, 2017, Precise submitted four additional trials of the
    tool to correct defects identified by Nexgen, which is a common practice in the
    industry. Nexgen never objected to the process or the overall quality of the
    work, and never threatened to stop working with Precise. Instead, upon
    receiving the fourth trial of the tool in November 2017, Nexgen asked Precise to
    pick up the tool and fix it, indicating a willingness to continue the project.
    After receiving the fifth trial of the tool, Gancher indicated the tool would be
    submitted for final testing and suggested Precise could submit its final invoice
    on December 1, 2017. Nexgen never communicated the test results to Precise
    or indicated that the fifth trial was defective.
    [26]   Similarly, during Dumoulin and Lukes’ email exchanges in January and
    February 2018 about Nexgen’s delinquent payments, Lukes never criticized the
    quality of the tool or the manufacturing process. Lukes instead blamed
    nonpayment on a cash flow problem and promised to pay Precise for its work.
    A reasonable person could have concluded from Nexgen’s lack of complaints
    about the fifth trial, and Lukes’ unqualified promise to pay, that the fifth trial
    met Nexgen’s requirements. As a result, there is evidence to support the trial
    court’s conclusions that Precise met its commitments under Purchase Order
    13251, and Nexgen breached its commitments by failing to pay.
    [27]   Nexgen points to other evidence to argue that the promise date of September
    13, 2017, was actually the date Precise should have delivered the final, defect-
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020   Page 9 of 11
    free version of the tool. Nexgen further cites other evidence to argue that
    Precise’s tool never met the contractual requirements and that Nexgen
    ultimately had to finish the work itself, incurring additional costs in the process.
    These arguments are requests to reweigh the evidence, which our standard of
    review forbids. See Ind. & Mich. Elec. Co. v. Terre Haute Indus., Inc., 
    507 N.E.2d 588
    (Ind. Ct. App. 1987) (affirming judgment for plaintiff in breach of contract
    case; parties presented conflicting evidence as to who had breached the
    contract, but the evidence favorable to the trial court’s judgment was sufficient
    to sustain the findings and conclusions), trans. denied.
    [28]   Next, Nexgen claims that Precise violated an express warranty that the tool
    would meet Nexgen’s requirements and further claims that Precise was not
    entitled to attorney’s fees at trial. These claims are based on Nexgen’s
    argument that Precise breached the contract first, and the evidence as found by
    the trial court, with ample support in the record, does not support that
    argument. We need not address the claims further. See Snellenbarger v. Kunz,
    
    798 N.E.2d 523
    , 528 (Ind. Ct. App. 2003) (rejecting appellant’s argument that
    trial court should not have awarded certain damages; argument was based on
    “assumption that [appellant] was not in breach,” but evidence supported trial
    court’s contrary determination on breach of contract), trans. denied.
    [29]   On cross-appeal, Precise claims it is entitled to an award of appellate attorney’s
    fees pursuant to the contract. Quote Number 5444 provided that if the
    customer “fails to make any payment(s) in accordance with this Proposal,
    [Precise] shall be entitled to recover its reasonable attorneys’ fees and costs . . .
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020   Page 10 of 11
    incurred for any claim or lawsuit . . . .” Tr. Vol. 3, p. 5 (Ex. 1). This provision,
    and an identical provision in Quote Number 5663, was the basis for the trial
    court’s award of attorney’s fees.
    [30]   When a contract provides that attorney’s fees are recoverable, appellate
    attorney’s fees may also be awarded. Cavallo v. Allied Physicians of Michiana,
    LLC, 
    42 N.E.3d 995
    (Ind. Ct. App. 2015). Precise, as the prevailing party on
    appeal, is entitled to appellate attorney’s fees.
    [31]   For the reasons stated above, we affirm the judgment of the trial court and
    remand for a calculation of appellate attorney’s fees to be awarded to Precise.
    [32]   Judgment affirmed and remanded.
    Riley, J., and Pyle, J., concur.
    Court of Appeals of Indiana | Memorandum Decision 19A-CT-1369 | January 31, 2020   Page 11 of 11
    

Document Info

Docket Number: 19A-CT-1369

Filed Date: 1/31/2020

Precedential Status: Precedential

Modified Date: 1/31/2020